WO2002072757A3 - Novel proteins and nucleic acids encoding same - Google Patents

Novel proteins and nucleic acids encoding same Download PDF

Info

Publication number
WO2002072757A3
WO2002072757A3 PCT/US2002/006908 US0206908W WO02072757A3 WO 2002072757 A3 WO2002072757 A3 WO 2002072757A3 US 0206908 W US0206908 W US 0206908W WO 02072757 A3 WO02072757 A3 WO 02072757A3
Authority
WO
WIPO (PCT)
Prior art keywords
small molecule
molecule target
nucleic acids
acids encoding
polynucleotide
Prior art date
Application number
PCT/US2002/006908
Other languages
French (fr)
Other versions
WO2002072757A2 (en
Inventor
Muralidhara Padigaru
Kimberly A Spytek
Suresh G Shenoy
Raymond J Taupier
Carol E A Pena
Li Li
Bryan D Zerhusen
Original Assignee
Curagen Corp
Muralidhara Padigaru
Kimberly A Spytek
Suresh G Shenoy
Raymond J Taupier
Carol E A Pena
Li Li
Bryan D Zerhusen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/092,900 external-priority patent/US20040043382A1/en
Application filed by Curagen Corp, Muralidhara Padigaru, Kimberly A Spytek, Suresh G Shenoy, Raymond J Taupier, Carol E A Pena, Li Li, Bryan D Zerhusen filed Critical Curagen Corp
Priority to EP02713788A priority Critical patent/EP1427749A4/en
Priority to CA002440337A priority patent/CA2440337A1/en
Publication of WO2002072757A2 publication Critical patent/WO2002072757A2/en
Publication of WO2002072757A3 publication Critical patent/WO2002072757A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed, as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecules associated with diseases.
PCT/US2002/006908 2001-03-08 2002-03-08 Novel proteins and nucleic acids encoding same WO2002072757A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP02713788A EP1427749A4 (en) 2001-03-08 2002-03-08 Novel proteins and nucleic acids encoding same
CA002440337A CA2440337A1 (en) 2001-03-08 2002-03-08 Novel proteins and nucleic acids encoding same

Applications Claiming Priority (119)

Application Number Priority Date Filing Date Title
US27410101P 2001-03-08 2001-03-08
US27428101P 2001-03-08 2001-03-08
US27419401P 2001-03-08 2001-03-08
US27432201P 2001-03-08 2001-03-08
US60/274,194 2001-03-08
US60/274,101 2001-03-08
US60/274,322 2001-03-08
US60/274,281 2001-03-08
US27484901P 2001-03-09 2001-03-09
US60/274,849 2001-03-09
US27523501P 2001-03-12 2001-03-12
US60/275,235 2001-03-12
US27557801P 2001-03-13 2001-03-13
US27557901P 2001-03-13 2001-03-13
US27560101P 2001-03-13 2001-03-13
US60/275,578 2001-03-13
US60/275,601 2001-03-13
US60/275,579 2001-03-13
US27600001P 2001-03-14 2001-03-14
US60/276,000 2001-03-14
US27677601P 2001-03-16 2001-03-16
US60/276,776 2001-03-16
US27699401P 2001-03-19 2001-03-19
US60/276,994 2001-03-19
US27732101P 2001-03-20 2001-03-20
US27733801P 2001-03-20 2001-03-20
US27732701P 2001-03-20 2001-03-20
US27723901P 2001-03-20 2001-03-20
US60/277,327 2001-03-20
US60/277,321 2001-03-20
US60/277,239 2001-03-20
US27779101P 2001-03-21 2001-03-21
US60/277,791 2001-03-21
US27783301P 2001-03-22 2001-03-22
US60/277,833 2001-03-22
US60/278,152 2001-03-23
US60/278,894 2001-03-26
US60/279,036 2001-03-27
US60/278,999 2001-03-27
US60/279,344 2001-03-28
US27999501P 2001-03-30 2001-03-30
US60/279,995 2001-03-30
US60/277,338 2001-03-30
US60/280,233 2001-03-30
US28090001P 2001-04-02 2001-04-02
US28082201P 2001-04-02 2001-04-02
US60/280,900 2001-04-02
US60/280,822 2001-04-02
US60/280,802 2001-04-02
US28119401P 2001-04-03 2001-04-03
US60/281,194 2001-04-04
US28367501P 2001-04-13 2001-04-13
US60/283,675 2001-04-13
US28742401P 2001-04-30 2001-04-30
US60/287,424 2001-04-30
US28806601P 2001-05-02 2001-05-02
US60/288,066 2001-05-02
US28834201P 2001-05-03 2001-05-03
US28852801P 2001-05-03 2001-05-03
US60/288,342 2001-05-03
US60/288,528 2001-05-03
US29119001P 2001-05-15 2001-05-15
US60/291,190 2001-05-15
US29124001P 2001-05-16 2001-05-16
US29109901P 2001-05-16 2001-05-16
US60/291,099 2001-05-16
US60/291,240 2001-05-16
US29448501P 2001-05-30 2001-05-30
US60/294,485 2001-05-30
US29489901P 2001-05-31 2001-05-31
US29488901P 2001-05-31 2001-05-31
US60/294,889 2001-05-31
US60/294,899 2001-05-31
US29902701P 2001-06-18 2001-06-18
US60/299,027 2001-06-18
US29930301P 2001-06-19 2001-06-19
US29931001P 2001-06-19 2001-06-19
US60/299,310 2001-06-19
US60/299,303 2001-06-19
US30435401P 2001-07-10 2001-07-10
US60/304,354 2001-07-10
US30919801P 2001-07-31 2001-07-31
US60/309,198 2001-07-31
US31290301P 2001-08-16 2001-08-16
US60/312,903 2001-08-16
US31846201P 2001-09-10 2001-09-10
US60/318,462 2001-09-10
US31877001P 2001-09-12 2001-09-12
US60/318,770 2001-09-12
US32543001P 2001-09-27 2001-09-27
US32568101P 2001-09-27 2001-09-27
US60/325,681 2001-09-27
US60/325,430 2001-09-27
US33038001P 2001-10-18 2001-10-18
US60/330,380 2001-10-18
US33530101P 2001-10-31 2001-10-31
US60/335,301 2001-10-31
US33227201P 2001-11-14 2001-11-14
US33318401P 2001-11-14 2001-11-14
US33227101P 2001-11-14 2001-11-14
US33217201P 2001-11-14 2001-11-14
US60/333,184 2001-11-14
US60/332,272 2001-11-14
US60/333,272 2001-11-14
US60/332,271 2001-11-14
US60/332,172 2001-11-14
US33209401P 2001-11-21 2001-11-21
US32209401P 2001-11-21 2001-11-21
US60/332,094 2001-11-21
US33809201P 2001-12-03 2001-12-03
US33742601P 2001-12-03 2001-12-03
US60/337,426 2001-12-03
US60/338,092 2001-12-03
US33718501P 2001-12-04 2001-12-04
US60/337,185 2001-12-04
US34570502P 2002-01-03 2002-01-03
US60/345,705 2002-01-03
US10/092,900 US20040043382A1 (en) 2001-03-08 2002-03-07 Novel proteins and nucleic acids encoding same
US10/092,900 2002-03-07

Publications (2)

Publication Number Publication Date
WO2002072757A2 WO2002072757A2 (en) 2002-09-19
WO2002072757A3 true WO2002072757A3 (en) 2004-04-15

Family

ID=32097249

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/006908 WO2002072757A2 (en) 2001-03-08 2002-03-08 Novel proteins and nucleic acids encoding same

Country Status (1)

Country Link
WO (1) WO2002072757A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008332B2 (en) 2006-05-31 2011-08-30 Takeda San Diego, Inc. Substituted indazoles as glucokinase activators
US8034822B2 (en) 2006-03-08 2011-10-11 Takeda San Diego, Inc. Glucokinase activators
US8124617B2 (en) 2005-09-01 2012-02-28 Takeda San Diego, Inc. Imidazopyridine compounds
US8163779B2 (en) 2006-12-20 2012-04-24 Takeda San Diego, Inc. Glucokinase activators
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03005500A (en) 2000-12-22 2004-04-20 Bristol Myers Squibb Co A novel human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1.
ATE415418T1 (en) * 2001-04-10 2008-12-15 Agensys Inc NUCLEIC ACID AND CORRESPONDING PROTEIN NAMED 121P2A3 FOR THE TREATMENT AND DETECTION OF CANCER
US20040253597A1 (en) * 2001-09-17 2004-12-16 Atsushi Nakanishi Novel protein and dna thereof
EP1491630B1 (en) * 2002-03-14 2009-11-11 National Institute of Advanced Industrial Science and Technology N-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146868A (en) * 1999-08-09 2000-11-14 Research Development Foundation Glucuronoxylomannan (GXM)-O-acetylhydrolase of cryptococcus neoformans and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146868A (en) * 1999-08-09 2000-11-14 Research Development Foundation Glucuronoxylomannan (GXM)-O-acetylhydrolase of cryptococcus neoformans and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1427749A4 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124617B2 (en) 2005-09-01 2012-02-28 Takeda San Diego, Inc. Imidazopyridine compounds
US8034822B2 (en) 2006-03-08 2011-10-11 Takeda San Diego, Inc. Glucokinase activators
US8008332B2 (en) 2006-05-31 2011-08-30 Takeda San Diego, Inc. Substituted indazoles as glucokinase activators
US8394843B2 (en) 2006-05-31 2013-03-12 Takeda California, Inc. Substituted isoindoles as glucokinase activators
US8163779B2 (en) 2006-12-20 2012-04-24 Takeda San Diego, Inc. Glucokinase activators
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators

Also Published As

Publication number Publication date
WO2002072757A2 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
WO2003000842A3 (en) Novel proteins and nucleic acids encoding same
WO2002081498A3 (en) Novel proteins and nucleic acids encoding same
WO2003010327A3 (en) Novel proteins and nucleic acids encoding same
WO2001036645A3 (en) Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
WO2002072757A3 (en) Novel proteins and nucleic acids encoding same
WO2000053742A3 (en) Polynucleotides and proteins encoded thereby
WO2003040325A3 (en) Novel proteins and nucleic acids encoding same
WO2001049729A8 (en) Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use
WO2003083046A3 (en) Novel proteins and nucleic acids encoding same
WO2003023001A3 (en) Novel proteins and nucleic acids encoding same
WO2003029424A3 (en) Novel proteins and nucleic acids encoding same
WO2003064628A3 (en) Novel proteins and nucleic acids encoding same
WO2001074856A3 (en) Wnt-7b-like polypeptides and nucleic acids encoding same
WO2002002625A3 (en) Novel fibroblast growth factors and nucleic acids encoding same
WO2003102159A3 (en) Novel proteins and nucleic acids encoding same
WO2001070978A3 (en) Polypeptides and nucleic acids encoding same
WO2001062928A3 (en) Polypeptides and nucleic acids encoding same
WO2003025147A3 (en) Novel polynucleotides and proteins encoded thereby
WO2001061009A3 (en) Polypeptides and nucleic acids encoding same
WO2001044473A3 (en) Polypeptides and nucleic acids encoding same
WO2001036638A3 (en) Polypeptides and nucleic acids encoding same
WO2000061754A3 (en) Human proteins and polynucleotides encoding them
WO2003057854A3 (en) Novel proteins and nucleic acids encoding same
WO2003076642A3 (en) Novel proteins and nucleic acids encoding same
WO2004048512A3 (en) Novel proteins and nucleic acids encoding same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US US US US US US US US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2002245617

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2440337

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002713788

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWP Wipo information: published in national office

Ref document number: 2002713788

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002713788

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)